Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
US Stock MarketDetailed Quotes
Design Therapeutics (DSGN)
- 14.220
- +0.120+0.85%
Close May 8 16:00 ET
- 14.220
- 0.0000.00%
Post 20:01 ET
888.14MMarket Cap-11.85P/E (TTM)
14.600High13.965Low402.99KVolume14.020Open14.100Prev Close5.78MTurnover1.34%Turnover RatioLossP/E (Static)62.46MShares17.25052wk High4.07P/B426.43MFloat Cap3.10552wk Low--Dividend TTM29.99MShs Float50.500Historical High--Div Yield TTM4.50%Range %1.940Historical Low14.342Avg Price1Lot Size
Design Therapeutics (DSGN) Key Financial Indicators
DSGN Earnings per Share (EPS)
According to the latest financial report of Design Therapeutics, the latest earnings per share (TTM) for the company is -0.29. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
DSGN Free Cash Flow (FCF)
Interested in knowing about Design Therapeutics's free cash flow? The latest report shows it as -16.43M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
DSGN Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Design Therapeutics shows that the company's current ratio is 22.28, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
DSGN Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Design Therapeutics, the quick ratio is 22.05, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
DSGN Return on Equity (ROE)
Want to learn more about the financial health of Design Therapeutics? The latest ROE figure is -8.19%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
DSGN Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Design Therapeutics, the total asset return on investment (ROA) is -7.72%.
Currency: USD
Quarterly
Loading...
DSGN Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Design Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
DSGN Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Design Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm